Supplemental Data
Fig. S1. Concentration of unbound structures against over time plot for HVEM (dark red line) and peptide (light blue line) with restrains based on crystal structure of BTLA/HVEM complex and peptide (green) simulated with restrains based on the NMR structure; second order equation corresponding fitted curves to obtained data for HVEM (red) and for peptide with restrains based on crystal structure of BTLA/HVEM complex (cyan) and for peptide with restrains based on NMR structure of this peptide (green). Figure S4 . The peptide stability (mean ± SEM) in A) PBS buffer, B) medium was determined using RP-HPLC. The analysis was done by comparing the area under peaks in a control sample (peptide dissolved in water, time=0) and a sample after incubation in PBS or medium at time points: 0 h, 2 h, 3 h, 6 h, 24 h at 4 and 37°C. The experiments were performed for the three different peptide concentrations: 0.1, 1 and 5 mg/ml. For all concentrations of HVEM(14-39) peptide at 4° and 37°C the results were very similar (here the data for concentration 1 mg/ml at 4°C are presented). Fig. S7 . Cytotoxic assay. PBMC from 3 healthy donors were incubated with HVEM(14-39) peptide at 0, 0.1 and 5 mg/ml in culture medium for 6 and 24h. Cells were subsequently counted and labelled with a dead cell marker. Statistical analysis: one-way ANOVA (Kruskal-Wallis) followed by Dunn's test to compare each concentration to the control (0 mg/mL). S7 Fig. S8 . Superimposed structures of complexes of BTLA protein (purple) with peptides (cyan and green) and with HVEM (red). Complex structures were superimposed after the structure of the BTLA protein. Table S3 . Derviation of associtation and dissociation rate constant for complex formation reaction.
